Novea Skin Center, 67051 Avezzano, Italy.
Plastic Surgery Unit, Section of Dermatology, Campus Biomedico University, 00128 Rome, Italy.
Medicina (Kaunas). 2023 Jul 4;59(7):1245. doi: 10.3390/medicina59071245.
: Photo/chrono-aging is usually expressed as facial discolouration, wrinkles, redness, elastosis, laxity, and dehydration, thus representing major signs of ageing that often lead to a negative phycological impact on a patient's quality of life. Several types of treatment have been tested during the last decade, especially laser treatments. This article aims to share our experience in the treatment of photoaging with a new 675 nm laser source system on facial chrono-ageing. : Thirty-five (35) patients were treated with the 675 nm laser device: 32 females (mean age 49 years) and 3 men (mean age 57 years), with Fitzpatrick skin types I-III (9% type I, 43% type II, 48% type III), facial wrinkles and hyperpigmented spots. The efficacy of this treatment was assessed using the Modified Fitzpatrick Wrinkles Scale (FWS), which was calculated before starting the treatment and after 6 months. The pain was evaluated using the VAS Pain Scale. : All 35 patients showed a significant improvement in facial wrinkles according to the FWS (from 1.96 to 1.73 at the 3-month follow-up, up to a value of 1.43 at 6 months). In a small group of patients, it was observed that 44% of them showed vascular moderate improvement and that 13% showed a vascular marked improvement after treatment. No side effects were detected except a mild erythematous rash in two patients, and the VAS Pain scale was assessed at 1.17. : Red Touch allows a uniform and stable result to be achieved over time with minimum discomfort.
照片/时龄老化通常表现为面部变色、皱纹、发红、弹性丧失、松弛和脱水，因此代表了衰老的主要迹象，这往往会对患者的生活质量产生负面影响。在过去十年中，已经测试了几种类型的治疗方法，尤其是激光治疗。本文旨在分享我们使用新型 675nm 激光源系统对面部时龄老化进行光老化治疗的经验。
共有 35 名患者接受了 675nm 激光设备治疗：32 名女性（平均年龄 49 岁）和 3 名男性（平均年龄 57 岁），皮肤类型为 I-III 型（9%为 I 型，43%为 II 型，48%为 III 型），面部皱纹和色素沉着斑。使用改良的 Fitzpatrick 皱纹量表（FWS）评估治疗效果，在开始治疗前和治疗后 6 个月进行评估。疼痛使用 VAS 疼痛量表进行评估。
所有 35 名患者的面部皱纹均有明显改善，根据 FWS 评估（治疗后 3 个月从 1.96 降至 1.73，6 个月时降至 1.43）。在一小部分患者中，观察到 44%的患者血管中度改善，13%的患者治疗后血管明显改善。除了两名患者出现轻度红斑外，未发现任何副作用，VAS 疼痛评分为 1.17。
Red Touch 可以实现均匀、稳定的效果，同时最大限度地减少不适感。
